| scholarly article | Q13442814 |
| P50 | author | Stephen Swisher | Q89454225 |
| P2093 | author name string | Thomas A Buchholz | |
| Jing Jiang | |||
| Benjamin D Smith | |||
| Joe Y Chang | |||
| Shervin M Shirvani | |||
| James Welsh | |||
| Anna Likhacheva | |||
| P2860 | cites work | Reduced lung-cancer mortality with low-dose computed tomographic screening | Q28241954 |
| A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
| Development of a comorbidity index using physician claims data | Q30623996 | ||
| Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population | Q30714715 | ||
| Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER data | Q33615631 | ||
| Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis | Q33997877 | ||
| Stereotactic body radiation therapy for inoperable early stage lung cancer | Q34010065 | ||
| Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases | Q34439990 | ||
| Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group | Q34721402 | ||
| Variable selection for propensity score models | Q34803815 | ||
| Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples | Q36319710 | ||
| Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. | Q36773986 | ||
| Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung Project | Q37118825 | ||
| Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly | Q37180820 | ||
| Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients? | Q37221925 | ||
| A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies | Q37461037 | ||
| Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? | Q37773607 | ||
| Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group | Q39605645 | ||
| A survey of stereotactic body radiotherapy use in the United States | Q39771088 | ||
| Future of cancer incidence in the United States: burdens upon an aging, changing nation | Q39983611 | ||
| Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer | Q44377522 | ||
| Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery | Q45395354 | ||
| Adoption of intensity-modulated radiation therapy for breast cancer in the United States | Q45790102 | ||
| A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients. | Q47828118 | ||
| Counterpoint: are limited resections appropriate in non-small cell lung cancer? No: don't overdo it, and don't get confused. | Q51407932 | ||
| Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. | Q53299557 | ||
| Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. | Q53667358 | ||
| Outcomes of Stereotactic Ablative Radiotherapy in Patients With Potentially Operable Stage I Non-Small Cell Lung Cancer | Q59587407 | ||
| Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study | Q79135631 | ||
| Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer | Q80845569 | ||
| Limited resection for the treatment of patients with stage IA lung cancer | Q82922999 | ||
| Point: are limited resections appropriate in non-small cell lung cancer? Yes | Q83587677 | ||
| Anatomic segmentectomy for stage I non-small cell lung cancer in the elderly | Q83888954 | ||
| Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer | Q83946997 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| P304 | page(s) | 1244-1253 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | JAMA Surgery | Q4787309 |
| P1476 | title | Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly | |
| P478 | volume | 149 |
| Q35783604 | "Old people suffer the ravages of the years": changes of treatments in elderly patients with early stage non-small cell lung cancer. |
| Q48256303 | A SUVmax-based propensity matched analysis of stereotactic body radiotherapy versus surgery in stage I non-small cell lung cancer: unveiling the role of 18F-FDG PET/CT in clinical decision-making |
| Q37552170 | A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly |
| Q93347944 | A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer |
| Q38790915 | A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer |
| Q30993385 | Additional data in the debate on stage I non-small cell lung cancer: surgery versus stereotactic ablative radiotherapy. |
| Q47222097 | American Society of Anesthesiologists physical status facilitates risk stratification of elderly patients undergoing thoracoscopic lobectomy |
| Q98771257 | An Externally-Validated Dynamic Nomogram Based on Clinicopathological Characteristics for Evaluating the Risk of Lymph Node Metastasis in Small-Size Non-small Cell Lung Cancer |
| Q64080784 | Big data, big contributions: outcomes research in thoracic surgery |
| Q38785099 | Challenges to delivery and effectiveness of adjuvant radiation therapy in elderly patients with node-positive vulvar cancer |
| Q55235684 | Combining radiation plus immunotherapy to improve systemic immune response. |
| Q46444793 | Comorbidity Profiles and Their Effect on Treatment Selection and Survival among Patients with Lung Cancer. |
| Q35812234 | Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer |
| Q90329536 | Comparing apples to oranges: short-term mortality after surgery versus stereotactic body radiotherapy for early-stage non-small cell lung cancer |
| Q27309908 | Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults |
| Q42907076 | Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens |
| Q60908706 | Developments in Stereotactic Body Radiotherapy |
| Q51478102 | Does segmentectomy really preserve the pulmonary function better than lobectomy for patients with early-stage lung cancer? |
| Q38763935 | Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach? |
| Q33639144 | Impact of maximum standardized uptake value of non-small cell lung cancer on detecting lymph node involvement in potential stereotactic body radiotherapy candidates |
| Q30985297 | Improved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data |
| Q38861915 | Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States |
| Q26749371 | Is surgery still the optimal treatment for stage I non-small cell lung cancer? |
| Q64997326 | Lobectomy versus stereotactic ablative radiotherapy for medically operable patients with stage IA non-small cell lung cancer: A virtual randomized phase III trial stratified by age. |
| Q37077160 | Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis |
| Q38990272 | Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer |
| Q26747777 | Lung cancer screening in patients with chronic obstructive pulmonary disease |
| Q35880933 | Outcomes after Stereotactic Body Radiotherapy versus Limited Resection in Older Patients with Early-Stage Lung Cancer. |
| Q47651774 | Patterns of Treatment and Outcomes for Definitive Therapy of Early Stage Non-Small Cell Lung Cancer. |
| Q48202266 | Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1). |
| Q63365851 | Racial disparities in guideline-concordant cancer care and mortality in the United States |
| Q46034873 | Real-time tomosynthesis for radiation therapy guidance. |
| Q58801338 | Real-world treatment patterns for patients 80 years and older with early lung cancer: a nationwide claims study |
| Q38813253 | SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer? |
| Q42384628 | SBRT versus lobectomy in stage I NSCLC: knowns, unknowns and its interpretation |
| Q40308740 | Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer |
| Q42558770 | Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer |
| Q35783598 | Stereotactic ablative radiotherapy and surgery: two gold standards for early-stage non-small cell lung cancer? |
| Q30656342 | Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials |
| Q41850996 | Stereotactic ablative radiotherapy: aim for a cure of cancer |
| Q57172947 | Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances |
| Q55062398 | Stereotactic body radiation therapy vs. surgery in early-stage non-small cell lung cancer: lessons learned, current recommendations, future directions. |
| Q89870886 | Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early-stage non-small cell lung cancer |
| Q38374340 | Stereotactic body radiotherapy in operable patients with stage I NSCLC: where is the evidence? |
| Q28076058 | Stereotactic body radiotherapy: current strategies and future development |
| Q35824255 | Stereotactic radiotherapy for early stage non-small cell lung cancer |
| Q91726001 | Sublobar resection is associated with better perioperative outcomes in elderly patients with clinical stage I non-small cell lung cancer: a multicenter retrospective cohort study |
| Q36230657 | Sublobar resection is associated with improved outcomes over radiotherapy in the management of high-risk elderly patients with Stage I non-small cell lung cancer: a systematic review and meta-analysis. |
| Q99566184 | Subsolid pulmonary nodules: Controversy and perspective |
| Q93064488 | Substantial imbalance that is never eliminated with propensity score matched analyses in comparing surgery to stereotactic body radiotherapy for patients with early-stage non-small cell lung cancer |
| Q90087984 | Surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer: review of meta-analyses |
| Q38367507 | Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future? |
| Q47781280 | Surgery or stereotactic body radiotherapy for elderly stage I lung cancer? A propensity score matching analysis. |
| Q42354883 | Surgery versus SABR for early stage non-small cell lung cancer: the moving target of equipoise |
| Q48369218 | Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review. |
| Q58764285 | Surgical Resection Versus Stereotactic Body Radiation Therapy for Stage I NSCLC: Can Randomized Trials Provide the Solution? |
| Q38751141 | The future of image-guided radiotherapy will be MR guided |
| Q50138849 | The great debate flashes: Surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer |
| Q64111832 | Three discipline collaborative radiation therapy (3 DCRT ) special debate: I would treat all early‐stage NSCLC patients with SBRT |
| Q30693104 | Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy |
| Q92645649 | Treatment strategy and decision-making for elderly surgical candidates with early lung cancer |
| Q27027385 | Update in Lung Cancer 2014 |
| Q92325978 | Uptake of Video-Assisted Thoracoscopic Lung Resections Within the Veterans Affairs for Known or Suspected Lung Cancer |
| Q92467682 | Which patients benefit most from stereotactic body radiotherapy or surgery in medically operable non-small cell lung cancer? An in-depth look at patient characteristics on both sides of the debate |
| Q88208674 | [Different mortality after surgery and stereotactic body radiotherapy for early-stage non-small-cell lung cancer] |
Search more.